JRCT ID: jRCTs031180261
Registered date:13/03/2019
CAPTEM treatment for neuroendocrine tumor
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | Performance status 0 or 1, no severe renal, heart, lung and liver dysfunction |
| Date of first enrollment | 07/10/2016 |
| Target sample size | 30 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | drug therapy |
Outcome(s)
| Primary Outcome | Response rate |
|---|---|
| Secondary Outcome | Progression free survival, overall survival, adverse event |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | < 76age old |
| Gender | Both |
| Include criteria | Unresecrable neuroendocrine tumor |
| Exclude criteria | Other treatment was stopped before 4 weeks and surgical resection was stopped before 3 months |
Related Information
| Primary Sponsor | Ichikawa Yasushi |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Yokohama City University Hospital Advanced Treatment Supportive Organazation |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Noritoshi Kobayashi |
| Address | Fuku-ura 3-9 Kanagawa ward Yokohama City Kanagawa Japan 236-0004 |
| Telephone | +81-45-787-2623 |
| norikoba@yokohama-cu.ac.jp | |
| Affiliation | Yokohama City University Hospital |
| Scientific contact | |
| Name | Yasushi Ichikawa |
| Address | Fuku-ura 3-9 Kanagawa ward Yokohama City Kanagawa Japan 236-0004 |
| Telephone | +81-45-787-2623 |
| yasu0514@yokohama-cu.ac.jp | |
| Affiliation | Yokohama City University Hospital |